| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.9519 | 22 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.2889 | 5 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.2389 | 14 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.4747 | 34 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.9363 | 41 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.3666 | 11 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 36.661 | 1 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.6947 | 26 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.4466 | 15 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.1751 | 23 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 38.9687 | 4 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.0216 | 9 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.1048 | 10 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.6557 | 40 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.9531 | 13 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.9019 | 13 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 38.8631 | 4 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.3602 | 11 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.3734 | 15 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.7009 | 8 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.044 | 10 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.0124 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 34.74 | 1 |